Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

476.91
-10.8100-2.22%
Post-market: 477.380.4700+0.10%16:15 EDT
Volume:374.37K
Turnover:178.60M
Market Cap:11.00B
PE:-33.55
High:492.33
Open:486.37
Low:466.06
Close:487.72
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:1.41
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:20.99
PE(LYR):-37.11

Loading ...

Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants

GlobeNewswire
·
Oct 06

Barclays Keeps Their Buy Rating on Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
Sep 30

HCA, Tenet, CoreWeave, Microsoft, Madrigal Trending With Analysts

TIPRANKS
·
Sep 26

Madrigal Pharmaceuticals Price Target Announced at $704.00/Share by Goldman Sachs

Dow Jones
·
Sep 24

Madrigal Pharmaceuticals resumed with a Buy at Goldman Sachs

TIPRANKS
·
Sep 24

Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target

MT Newswires Live
·
Sep 23

Madrigal Pharmaceuticals, Inc. : Citigroup Initiates Coverage with Buy Rating; Price Target $725

THOMSON REUTERS
·
Sep 23

Madrigal Pharmaceuticals initiated with a Buy at Citi

TIPRANKS
·
Sep 23

Madrigal Pharmaceuticals management to meet with Oppenheimer

TIPRANKS
·
Sep 19

Madrigal Grants Inducement Equity Awards to 27 New Hires, Including 2,754 Stock Options Priced at USD 538.71

Reuters
·
Sep 17

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 17

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 17

Madrigal Pharma CEO William John Sibold Disposes of Common Shares Worth $4.16 Million

Reuters
·
Sep 12

Madrigal Pharmaceuticals to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 02

Can Madrigal Pharmaceuticals (MDGL) Still Offer Value After Its Big Run?

Simply Wall St.
·
Aug 29

Movement Alert|Madrigal Pharmaceuticals Rises 5.08% in Regular Trading, Trading at $537.92

Market Focus
·
Aug 27

Madrigal Grants 4,676 Inducement RSUs to 13 New Employees Under 2025 Plan

Reuters
·
Aug 21

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 21

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 21

Madrigal Pharmaceuticals (MDGL) Stock May Look Cheap On Sales But Risky On Cash Flow

Simply Wall St.
·
Aug 20